LIVN 8-K 2026-11-04

LivaNova PLC (LIVN) 8-K dated 2026-11-04 — accession 0001639691-26-000111.

LivaNova PLC (LIVN) is a medical devices company listed on NASDAQ.

LivaNova PLC filed a 8-K on 2026-11-04. Accession 0001639691-26-000111.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported LIVN revenue for 2025-12-31 was $1.39B. Net income was -$242.5M. Revenue was up 10.7% from 2024-12-31 to 2025-12-31. LIVN currently screens at market cap $4.40B.

Not investment advice. The LIVN SEC hub lists recent forms. The stock page is the research view.